Literature DB >> 9251546

Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register.

N Brown1, T Young, D Gray, A M Skene, J R Hampton.   

Abstract

OBJECTIVE: To assess longitudinal trends in admissions, management, and inpatient mortality from acute myocardial infarction over 10 years.
DESIGN: Retrospective analysis based on the Nottingham heart attack register.
SETTING: Two district general hospitals serving a defined urban and rural population.
SUBJECTS: All patients admitted with a confirmed acute myocardial infarction during 1982-4 and 1989-92 (excluding 1991, when data were not collected). MAIN OUTCOME MEASURES: Numbers of patients, background characteristics, time from onset of symptoms to admission, ward of admission, treatment, and inpatient mortality.
RESULTS: Admissions with acute myocardial infarction increased from 719 cases in 1982 to 960 in 1992. The mean age increased from 62.1 years to 66.6 years (P < 0.001), the duration of stay fell from 8.7 days to 7.2 days (P < 0.001), and the proportion of patients aged 75 years and over admitted to a coronary care unit increased significantly from 29.1% to 61.2%. A higher proportion of patients were admitted to hospital within 6 hours of onset of their symptoms in 1989-92 than in 1982-4, but 15% were still admitted after the time window for thrombolysis. Use of beta blockers increased threefold between 1982 and 1992, aspirin was used in over 70% of patients after 1989, and thrombolytic use increased 1.3-fold between 1989 and 1992. Age and sex adjusted odds ratios for inpatient mortality remained unchanged over the study period.
CONCLUSIONS: Despite an increasing uptake of the "proved" treatments, inpatient mortality from myocardial infarction did not change between 1982 and 1992.

Entities:  

Mesh:

Year:  1997        PMID: 9251546      PMCID: PMC2127135          DOI: 10.1136/bmj.315.7101.159

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  13 in total

Review 1.  Spirituality in medicine: what is to be done?

Authors:  A Yawar
Journal:  J R Soc Med       Date:  2001-10       Impact factor: 5.344

2.  Primary angioplasty should be first line treatment for acute myocardial infarction: AGAINST.

Authors:  Kevin S Channer
Journal:  BMJ       Date:  2004-05-22

3.  Regional variation in incidence and case fatality of myocardial infarction among young women in England, Scotland and Wales.

Authors:  N R Dunn; A Arscott; M Thorogood; B Faragher; L de Caestecker; T M MacDonald; C McCollum; S Thomas; R D Mann
Journal:  J Epidemiol Community Health       Date:  2000-04       Impact factor: 3.710

4.  Age related outcome in acute myocardial infarction. Elderly people benefit from thrombolysis and should be included in trials.

Authors:  S R McMechan; A A Adgey
Journal:  BMJ       Date:  1998-11-14

Review 5.  Clinical guidelines-the hidden costs.

Authors:  A Haycox; A Bagust; T Walley
Journal:  BMJ       Date:  1999-02-06

6.  Hospital mortality of acute myocardial infarction in the thrombolytic era.

Authors:  N G Mahon; C O'rorke; M B Codd; H A McCann; K McGarry; D D Sugrue
Journal:  Heart       Date:  1999-05       Impact factor: 5.994

7.  Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996.

Authors:  J V Tu; C D Naylor; P Austin
Journal:  CMAJ       Date:  1999-11-16       Impact factor: 8.262

8.  The development of a simulation model of the treatment of coronary heart disease.

Authors:  Keith Cooper; Ruth Davies; Paul Roderick; Debbie Chase; James Raftery
Journal:  Health Care Manag Sci       Date:  2002-11

9.  Prognostic implications of ventricular fibrillation in acute myocardial infarction: new strategies required for further mortality reduction.

Authors:  J W Sayer; R A Archbold; P Wilkinson; S Ray; K Ranjadayalan; A D Timmis
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

10.  Changing the diagnostic criteria for myocardial infarction in patients with a suspected heart attack affects the measurement of 30 day mortality but not long term survival.

Authors:  C Packham; D Gray; C Weston; A Large; P Silcocks; J Hampton
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.